-- 
Aneka, Kalbe Farma, Ramayana Lestari: Indonesia Equity Preview

-- B y   B e r n i   M o e s t a f a
-- 
2011-09-30T01:56:49Z

-- http://www.bloomberg.com/news/2011-09-30/aneka-kalbe-farma-ramayana-lestari-indonesia-equity-preview.html
Shares of the following companies
may have unusual moves in Indonesian trading. Stock symbols are
in parentheses, and share prices are as of the previous close.  The  Jakarta Composite index (JCI)  gained 0.7 percent to 3,537.18.  PT Aneka Tambang (ANTM IJ): The company’s first-half
audited net income rose 35 percent from a year earlier to 1.02
trillion rupiah ($116 million), Aneka Tambang, the nation’s
second-largest nickel producer, said in a statement published in
Investor Daily today. Aneka Tambang fell 0.7 percent to 1,440
rupiah.  PT Clipan Finance  Indonesia  (CFIN IJ): The leasing and
consumer financing company plans to sell as much as 500 billion
rupiah of bonds in October to boost working capital, it said in
a statement published today in  Bisnis Indonesia . Clipan Finance
declined 2.3 percent to 435 rupiah.  PT Kalbe Farma (KLBF IJ):  Southeast Asia ’s largest
drugmaker created a three-person team to help it find
acquisitions in the region, including producers of consumer
health-care products, Chief Financial Officer Vidjongtius said.
Kalbe Farma climbed 1.6 percent to 3,275 rupiah.  PT Ramayana Lestari Sentosa (RALS IJ): The retailer expects
to increase sales by 20 percent in 2012, Kontan reported, citing
Setyadi Surya, a director at the company. Ramayana plans to
boost sales by 14 percent this year, the newspaper said. The
stock fell 1.4 percent to 680 rupiah.  To contact the reporter on this story:
Berni Moestafa in Jakarta at 
 bmoestafa@bloomberg.net   To contact the editor responsible for this story:
Darren Boey at   dboey@bloomberg.net  